Clinical Trials Logo

Limited Metastatic Disease clinical trials

View clinical trials related to Limited Metastatic Disease.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02735850 Withdrawn - NSCLC Stage IV Clinical Trials

Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR)

ImmunoSABR
Start date: December 2015
Phase: Phase 2
Study type: Interventional

This will be a phase II trial testing if the combination of SBRT and L19-IL2 improves the progression free survival in patients with limited metastatic non-small cell lung cancer (NSCLC). Treatment will be divided in two cohorts: patients eligible for ablative stereotactic body radiotherapy to all metastatic sites (treatment with curative intent) and patients not eligible for stereotactic body radiotherapy to all sites (life prolongation).